Age-Related Macular Degeneration Risk Score (AREDS2)

Calculates AREDS2 5-year AMD progression risk based on drusen size, pigment changes, and pseudodrusen, and determines AREDS2 supplement eligibility (antioxidants + zinc, lutein, zeaxanthin, omega-3).

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Calculates AREDS2 5-year AMD progression risk based on drusen size, pigment changes, and pseudodrusen, and determines AREDS2 supplement eligibility (antioxidants + zinc, lutein, zeaxanthin, omega-3)

Each component has a specific meaning:

  • Drusen size — The drusen size recorded for the patient or scenario being assessed.
  • Pigment changes — The pigment changes recorded for the patient or scenario being assessed.
  • Pseudodrusen — The pseudodrusen recorded for the patient or scenario being assessed.
  • Determines AREDS2 supplement eligibility (antioxidants + zinc — The determines areds2 supplement eligibility (antioxidants + zinc recorded for the patient or scenario being assessed.
  • Lutein — The lutein recorded for the patient or scenario being assessed.
  • Zeaxanthin — The zeaxanthin recorded for the patient or scenario being assessed.

Note: Interpret the amd risk score result against the clinical thresholds and context described above.

How to Use

Enter the drusen size, pigment changes, pseudodrusen, determines AREDS2 supplement eligibility (antioxidants + zinc, lutein, zeaxanthin for the patient or scenario you are assessing. Calculates AREDS2 5-year AMD progression risk based on drusen size, pigment changes, and pseudodrusen, and determines AREDS2 supplement eligibility (antioxidants + zinc, lutein, zeaxanthin, omega-3). Use the amd risk score result to inform your clinical assessment.

Frequently Asked Questions